版本:
中国

BRIEF-Veracyte says CMS has determined Afirma gene expression classifier's current rate will be maintained in 2017

Nov 22 Veracyte Inc :

* Says CMS has determined Afirma gene expression classifier's current rate of $3,200 will be maintained in 2017

* Says final rate replaces previously released lower "gapfill" amount and will go into effect on January 1, 2017 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐